Komori
Tachi-S (7239) · FactIncrease in R&D Spending

Continued Spending on Research and Development Activities

First written in FY2017-Q1. 25 of 28 entries say "Restated". Latest entry: FY2026.

28entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY20262016: 220162017: 420172018: 420182019: 320192020: 320202021: 320212022: 320222023: 220232024: 220242025: 120252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 212 companies write about · 0 as a headwind · 225 as a tailwind

91 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 227 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Increase in R&D SpendingAnnual report

    「Total R&D expenses for the current consolidated fiscal year across the Group were ¥4,713 million, incurred primarily in Japan.」

    R&D expenses increased from ¥3,689 million in the previous fiscal year to ¥4,713 million.
  2. FY2026-H1Interim R&D expenses decreasedAnnual report

    「Total R&D expenses for the current interim consolidated fiscal period were ¥1,640 million.」

    R&D expenses continued to be incurred, but decreased from ¥2,074 million in the same period of the previous year to ¥1,640 million.
  3. FY2025-H1RestatedAnnual report

    「Total R&D expenses for the current interim consolidated fiscal period were ¥2,074 million.」

    The Company continued to incur R&D expenses and disclosed ¥2,074 million for the current interim consolidated fiscal period.
  4. FY2024-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,496 million.」

    The Company continued to incur R&D expenses and disclosed ¥2,496 million for the cumulative third quarter.
  5. FY2024-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,053 million.」

    R&D spending disclosed at ¥1,053 million for the cumulative first quarter of the current fiscal year.
  6. FY2023RestatedAnnual report

    「Total R&D expenses for the current consolidated fiscal year across the Group were ¥3,661 million, incurred primarily in Japan.」

    The Company continued to incur R&D expenses and disclosed full-year R&D expenses of ¥3,661 million.
  7. FY2023-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1,709 million.」

    The Company continued to incur R&D expenses and disclosed ¥1,709 million for the cumulative second quarter.
  8. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,001 million.」

    R&D spending disclosed at ¥1,001 million for the cumulative first quarter.
  9. FY2022-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,323 million.」

    The Company continued to incur R&D expenses and disclosed ¥3,323 million for the cumulative third quarter.
  10. FY2022-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,066 million.」

    The Company continued to incur R&D expenses and disclosed ¥1,066 million for the cumulative first quarter of the current fiscal year.
  11. FY2021RestatedAnnual report

    「Total R&D expenses for the current consolidated fiscal year across the Group were ¥4,804 million, incurred primarily in Japan.」

    R&D spending updated to ¥4,804 million for the full year. This was down from ¥5,554 million in the previous fiscal year.
  12. FY2021-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,487 million.」

    R&D spending updated to ¥3,487 million for the cumulative third quarter.
  13. FY2021-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥2,251 million.」

    R&D spending updated to ¥2,251 million for the cumulative second quarter.
  14. FY2021-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,196 million.」

    R&D spending updated to ¥1,196 million, the total for the cumulative first quarter of the current fiscal year.
  15. FY2020RestatedAnnual report

    「Total R&D expenses for the current consolidated fiscal year across the Group were ¥5,554 million, incurred primarily in Japan.」

    R&D spending updated to ¥5,554 million for the full year.
  16. FY2020-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥3,172 million.」

    R&D spending updated to ¥3,172 million for the cumulative second quarter.
  17. FY2020-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,573 million.」

    R&D spending updated to ¥1,573 million for the cumulative first quarter.
  18. FY2019-Q3RestatedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,510 million.」

    R&D spending updated to ¥3,510 million for the cumulative third quarter.
  19. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥2,495 million.」

    R&D spending updated to ¥2,495 million for the cumulative second quarter.
  20. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,306 million.」

    R&D spending updated to ¥1,306 million for the cumulative first quarter.
  21. FY2018RestatedAnnual report

    「Total research and development expenses for the Group as a whole for the current consolidated fiscal year were ¥4,647 million, incurred primarily in Japan.」

    R&D spending updated to ¥4,647 million for the full year.
  22. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥3,273 million.」

    The ongoing research and development expenditure has been updated to a cumulative total of ¥3,273 million for the third quarter.
  23. FY2018-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter of the current consolidated cumulative period were ¥2,411 million.」

    The ongoing research and development expenditure has been updated to a cumulative total of ¥2,411 million for the second quarter.
  24. FY2018-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥1,228 million.」

    The ongoing research and development expenditure has been updated to a cumulative total of ¥1,228 million for the quarter.
  25. FY2017RestatedAnnual report

    「Total research and development expenses for the Group as a whole for the current consolidated fiscal year were ¥4,130 million, incurred primarily in Japan.」

    The ongoing research and development expenditure has been updated to a full-year total of ¥4,130 million.
  26. FY2017-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥3,256 million.」

    The ongoing research and development expenditure has been updated to a cumulative total of ¥3,256 million for the third quarter.
  27. FY2017-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter of the current consolidated cumulative period were ¥1,990 million.」

    The ongoing research and development expenditure has been updated to a cumulative total of ¥1,990 million for the second quarter.
  28. FY2017-Q1First statedAnnual report

    「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥1,042 million.」

    The total research and development expenses for the quarter are disclosed, but the priority areas of research and development and future targets are not specified.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tachi-S yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.